Read the latest positive news, breakthroughs, and inspiring stories about immunotherapy breakthrough, curated daily by BrightWire.
Scientists at Penn State discovered how to make aggressive childhood tumors more visible to immunotherapy treatments, boosting survival chances. The breakthrough could help kids with high-risk neuroblastoma, one of childhood's deadliest cancers.
Scientists at Mayo Clinic discovered how to reprogram immune cells to fight glioblastoma, the deadliest brain cancer, while making existing chemotherapy work better. The breakthrough could transform treatment for thousands of patients facing this devastating diagnosis.
A Colorado teacher given months to live is now celebrating a decade in complete remission after pioneering immunotherapy turned her white blood cells into cancer-fighting warriors. Her story marks a major milestone in the evolution of CAR T-cell therapy from experimental treatment to lifesaving standard care.
A groundbreaking six-year study aims to solve one of cancer treatment's biggest puzzles: predicting which lung cancer patients will respond to immunotherapy. With $23.7 million in federal funding, City of Hope is mapping how tumors change to help doctors choose the right treatment from the start.
Scientists have discovered how to boost immune cells by changing their metabolism, opening a promising new path to treat skin cancers that resist current therapies. Clinical trials are already testing these metabolic treatments alongside immunotherapy.
A groundbreaking vaccine targeting a common mutation in deadly brain tumors helped two-thirds of patients survive eight years in a clinical trial. The treatment trains the immune system to hunt down cancer cells carrying the genetic error found in most gliomas.
A tablet that makes cancer cells visible to the immune system shrank tumors by at least 30% in patients who had run out of treatment options. The breakthrough could help the two-thirds of cancer patients for whom immunotherapy currently fails.
A Dalhousie University lab just received $725,000 to develop a breakthrough immunotherapy for ovarian cancer, with help from a 73-year-old survivor who's turning her diagnosis into hope for future generations. The team is now preparing for clinical trials that could make treatment more affordable and accessible.
UC San Diego researchers discovered how to "re-educate" immune cells to attack aggressive ovarian cancer by blocking a protein and triggering omega-3 signals. The breakthrough could make existing treatments far more effective for patients with limited options.
